Back to search results

Absorbable Staples vs. Stitches for Cesarean Delivery

This study is looking at different ways to close the skin after a cesarean delivery. Researchers want to see if using absorbable staples (Insorb device) is better than traditional stitches (Monocryl suture) for women having a C-section. They are comparing these two methods to see if one takes less time during surgery and if it leads to a better-looking wound. You might be able to join if you are a woman between 18 and 50 years old, are at least 24 weeks pregnant, and are having a cesarean delivery. The study is currently recruiting 237 participants.

Study design
This is an open-label, randomized controlled clinical trial. It plans to enroll 237 women.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, operating time, is measured from the start of surgery through the end of skin closure, up to 8 hours.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07167199

Absorbable Staples Versus Conventional Skin Closure in Women Undergoing Cesarean Delivery

Not Yet Recruiting
NAAges 18–50Interventional
Inova Health Care Services
~237 participants
Updated 2026-04-02 on ClinicalTrials.gov
What's tested:Subcuticular monocryl sutureSubcuticular absorbable staple using Insorb device

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Operating time
Measured over Time from the start of surgery through end of skin closure up to 8 hours

Conditions

Pregnancy

Explore related trials

Pregnancy

Where it's being run

1 sites across 1 states
Virginia1

Study leadership

  • Antonio Saad, MD · PRINCIPAL_INVESTIGATOR · Inova Fairfax Medical Center

Who to contact

Antonio Saad, MD
[email protected]
(703) 779-6040
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18-50 years of age
Women ≥ 24 weeks viable gestation
Will be undergoing cesarean delivery

Exclusion

Patient unwilling or unable to provide consent.
No or very limited prenatal care or a non-resident patient who is unlikely to follow-up after delivery.
Immunosuppressed subjects: i.e., taking systemic immunosuppressant or steroids (e.g. transplant subjects; not including steroids for lung maturity), HIV with CD4 \<200, or other
Decision not to have skin closure (e.g. secondary wound closure, mesh closure)
Current skin infection
Coagulopathy
High likelihood of additional surgical procedure beyond cesarean (e.g. scheduled hysterectomy, tubal ligation, bowel or adnexal surgery)
Incarcerated individuals
Intraamniotic infection
Subjects participating on other treatment trials or studies that would interfere with the current study's primary outcome.

What this trial measures

  • Operating timeTime from the start of surgery through end of skin closure up to 8 hours

    Total time for the procedure